Αρχική World News New on NCI’s Websites for June 2020

New on NCI’s Websites for June 2020

, by NCI Staff

Coronavirus and Cancer

NCI’s collection of cancer information products is constantly growing, so we provide periodic updates on new and updated content of interest to the cancer community.

Coronavirus Information for Patients and Researchers

Since the coronavirus emergency began, NCI has produced numerous pages with information about the virus, SARS-CoV-2, and the disease it causes, COVID-19, for both lay audiences and the research community. To help people quickly find the information they need, NCI has collected those pages into patient and researcher hubs. The coronavirus patient hub includes information about how patients with cancer can protect themselves, what they should do if they have symptoms of an infection, coping suggestions, and information about cancer clinical trials during the COVID-19 emergency. The coronavirus researcher hub includes information about guidance for the research community and funding opportunities. 

New Healthcare Delivery Research Program Resources

NCI’s Division of Cancer Control and Population Science (DCCPS) has produced two new web-based resources for its Healthcare Delivery Research Program. A new module of the PRO-CTCAE (a tool for patients to self-report treatment-related side effects experienced in cancer clinical trials) is now available to enable self-reporting by children and adolescents ages 7‒17 (Ped-PRO-CTCAE), or proxy reporting by a caregiver for children younger than 7 years of age (Ped-PRO-CTCAE [Caregiver])

The second resource is a new website for the SEERMedicaid Linked Data Resource. The linkage of these two large population-based data sources provides information about Medicaid beneficiaries with cancer, enabling an array of epidemiological and health services research.

DCCPS Websites Updated

DCCPS has also redesigned and added new data to its Classification of Laws Associated with School Students (CLASS) website. The CLASS site houses important information on physical education and nutrition policies across the United States to provide researchers, policymakers, and educators with data to examine the relationship between these policies and student and school outcomes, such as childhood inactivity and time allocated for physical education classes. 

Additionally, new data has been added to the websites of the Health Information National Trends Survey (HINTS), a project that collects nationally representative data on changes in health communication and information technology, and the Tobacco Use Supplement to the Current Population Survey (TUS-CPS), an NCI-sponsored survey of tobacco use administered as part of the US Census Bureau’s Current Population Survey. 

NCI Technology Research Advocacy Partnership

NCI’s Center for Strategic Scientific Initiatives recently launched a microsite for the NCI Technology Research Advocacy Partnership (NTRAP). NTRAP incorporates the perspective of cancer patients and survivors into programs that support the development of technologies that may improve cancer research.

NCI Cancer Research Data Commons Website Launched

NCI’s Center for Biomedical Informatics and Information Technology (CBIIT) has launched a new website for the NCI Cancer Research Data Commons (CRDC). The website serves as an entry point for visitors interested in accessing all current CRDC data repositories, analyzing data, reviewing available data sets and analytics tools, and learning more about the CRDC.

Cancer Data Science Pulse Blog

CBIIT has also published several new posts to its Cancer Data Science Pulse blog, including posts about a new Cancer Data Aggregator (CDA) tool that is currently being designed and developed, the DREAM Challenge to harmonize data, and a biography of CBIIT scientist Mervi Heiskanen, Ph.D. 

NCI News Release—Effective, Less Toxic Treatment for Adults with Burkitt Lymphoma

In a new study, a treatment regimen that is less toxic than standard dose-intensive chemotherapy was found to be highly effective for adults with Burkitt lymphoma across all age groups, regardless of HIV status. Besides being better tolerated, the regimen, called dose-adjusted (DA) EPOCH-R, is already a treatment option for diffuse large B-cell lymphomas and can be given in an outpatient setting.

NCI News Release—NIH Scientists Develop Blood Test to Help Improve Liver Cancer Screening

Scientists have developed a simple blood test that can help identify people likely to develop hepatocellular carcinoma (HCC), the most common form of liver cancer. The new test checks for the patient’s previous exposure to certain viruses and could help doctors find and treat HCC early.

Cancer Prevention Fellowship Program

NCI’s Division of Cancer Prevention is accepting applications for its Cancer Prevention Fellowship Program. This multidisciplinary postdoctoral program trains future leaders in the field of cancer prevention and control. The application period closes August 17.

Center for Global Health Cancer Control and Funding Opportunities

NCI’s Center for Global Health has announced several new funding opportunities, including applications for Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries and an Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research

New DCEG Linkage Articles

NCI’s Division of Cancer Epidemiology and Genetics (DCEG) has published several new articles in its Linkage newsletter. Among the topics covered are a study examining the global occurrence of gastrointestinal cancers, a meta-analysis of genome-wide association studies for cutaneous melanoma, and a study of the risk of death associated with low-intensity, nondaily smoking.  

CCR Websites Highlight Research Milestones

NCI’s Center for Cancer Research (CCR) has published a digital version of its 2020 Milestones collection of research highlights and updated its Research page to highlight areas of excellence, special initiatives, and research programs. CCR’s website also has a new section that features the center’s immunology and immunotherapy research and clinical trials. And the center has produced a Spanish-language microsite for its NCI-CONNECT brain and spine tumor program that includes information on diagnosis, symptoms, and treatment.

Videos—Clinical Trials for Brain and Spine Tumors

The NCI-CONNECT Clinic at NIH has published a series of videos for patients with rare brain and spine tumors and their physicians.

Advances in Lymphoma Research

NCI-funded researchers are working to advance the understanding of how to better prevent, detect, and treat lymphoma in adults and children. This new page highlights some of the latest research on lymphoma.

Infographic—What is SEER?

This infographic helps explain SEER, NCI’s program to track cancer cases and deaths in the United States. Data from this program show trends that help inform future research efforts.



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer

The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal,...

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn, the chancellor Rishi Sunak will go to Parliament and set out the UK Government’s spending priorities in the Comprehensive Spending Review...

FDA Extends Approval of Pembrolizumab for Classical Hodgkin Lymphoma

On 14 October 2020, the US Food and Drug Administration (FDA) extended the approval of pembrolizumab (KEYTRUDA®, Merck Sharp & Dohme Corp.) for the...

31-Year-Old Mother Dies of Cancer After Her Chemotherapy Was Paused During the Pandemic

The COVID-19 pandemic has been a scary and difficult thing for most of the world, and it’s important to keep safety protocols in place...

For Esophageal Cancer, Immunotherapy Likely to Play Larger Role

October 19, 2020, by NCI Staff An esophagram using barium contrast shows the esophagus. Credit: iStock Immunotherapy may become part of early treatment for some people with...

Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is Feasible

Targeted therapy recommendations can be made based on the molecular profiles of tumour samples from patients with metastatic malignant mesothelioma (MM) according to findings...